(Q40405425)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27988815%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

title

Novel portable platform for molecular detection of toxigenic Clostridium difficile in faeces: a diagnostic accuracy study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27988815%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

main subject

feces

0 references

Clostridium difficile

0 references

author

Jari J Hirvonen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27988815%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

author name string

P Matero

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27988815%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

C Siebert

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27988815%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

J Kauppila

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27988815%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

R Vuento

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27988815%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

H Tuokko

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27988815%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

S Boisset

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27988815%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

publication date

17 December 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27988815%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Clinical Microbiology & Infectious Diseases

30 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27988815%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27988815%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27988815%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

page(s)

783-789

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27988815%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10096-016-2860-0

30 March 2020

exact match

0 references

cites work

Rapid clinical bacteriology and its future impact

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2860-0

Molecular diagnostics for the detection and characterization of microbial pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2860-0

Nucleic acid detection and quantification in the developing world

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2860-0

Strand Invasion Based Amplification (SIBA®): a novel isothermal DNA amplification technology demonstrating high specificity and sensitivity for a single molecule of target analyte

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2860-0

Loop-mediated isothermal amplification of DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2860-0

Rapid and sensitive loop-mediated isothermal amplification test for Clostridium difficile detection challenges cytotoxin B cell test and culture as gold standard

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2860-0

Premarket evaluations of the IMDx C. difficile for Abbott m2000 Assay and the BD Max Cdiff Assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2860-0

Comparison of nine commercially available Clostridium difficile toxin detection assays, a real-time PCR assay for C. difficile tcdB, and a glutamate dehydrogenase detection assay to cytotoxin testing and cytotoxigenic culture methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2860-0

Detection of toxigenic Clostridium difficile: comparison of the cell culture neutralization, Xpert C. difficile, Xpert C. difficile/Epi, and Illumigene C. difficile assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2860-0

Emerging technologies for the clinical microbiology laboratory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2860-0

Molecular isothermal techniques for combating infectious diseases: towards low-cost point-of-care diagnostics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2860-0

Emerging technologies in point-of-care molecular diagnostics for resource-limited settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2860-0

Point-of-care tests for diagnosing infections in the developing world

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2860-0

Comparison of BD Max Cdiff and GenomEra C. difficile molecular assays for detection of toxigenic Clostridium difficile from stools in conventional sample containers and in FecalSwabs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2860-0

Overdiagnosis of Clostridium difficile Infection in the Molecular Test Era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2860-0

An evaluation of repeat stool testing for Clostridium difficile infection by polymerase chain reaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2860-0

Antimicrobial prescribing practices in response to different Clostridium difficile diagnostic methodologies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2860-0

Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2860-0

Clostridium difficile colonization and diarrhea at a tertiary care hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2860-0

Asymptomatic Clostridium difficile colonization in a tertiary care hospital: admission prevalence and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2860-0

Prevalence and risk factors for asymptomatic Clostridium difficile carriage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2860-0

Nosocomial diarrhea: evaluation and treatment of causes other than Clostridium difficile

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2860-0

Clinical and infection control implications of Clostridium difficile infection with negative enzyme immunoassay for toxin

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27988815

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Detection of Chlamydia trachomatis infections in women by Amplicor PCR: comparison of diagnostic performance with urine and cervical specimens.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27988815